MPC vs SGMO · P/E 16, rev $138.86B vs rev $57.8M
Marathon Petroleum Corp (MPC) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the MPC and SGMO stock pages for the full models.
Not investment advice.